annual working capital:
$435.21M+$22.60M(+5.48%)Summary
- As of today (July 1, 2025), PCRX annual working capital is $435.21 million, with the most recent change of +$22.60 million (+5.48%) on December 31, 2024.
- During the last 3 years, PCRX annual working capital has risen by +$90.28 million (+26.17%).
- PCRX annual working capital is now at all-time high.
Performance
PCRX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$445.23M+$10.02M(+2.30%)Summary
- As of today (July 1, 2025), PCRX quarterly working capital is $445.23 million, with the most recent change of +$10.02 million (+2.30%) on March 31, 2025.
- Over the past year, PCRX quarterly working capital has dropped by -$4.44 million (-0.99%).
- PCRX quarterly working capital is now -25.37% below its all-time high of $596.56 million, reached on September 30, 2021.
Performance
PCRX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
PCRX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -1.0% |
| 3 y3 years | +26.2% | +23.0% |
| 5 y5 years | +44.6% | +26.7% |
PCRX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.2% | -17.5% | +60.5% |
| 5 y | 5-year | at high | +44.6% | -25.4% | +60.5% |
| alltime | all time | at high | +2964.7% | -25.4% | +2026.7% |
PCRX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $445.23M(+2.3%) |
| Dec 2024 | $435.21M(+5.5%) | $435.21M(+13.5%) |
| Sep 2024 | - | $383.57M(-28.9%) |
| Jun 2024 | - | $539.52M(+20.0%) |
| Mar 2024 | - | $449.67M(+9.0%) |
| Dec 2023 | $412.61M(+17.7%) | $412.61M(+16.7%) |
| Sep 2023 | - | $353.59M(+10.4%) |
| Jun 2023 | - | $320.41M(+15.5%) |
| Mar 2023 | - | $277.42M(-20.9%) |
| Dec 2022 | $350.56M(+1.6%) | $350.56M(-12.8%) |
| Sep 2022 | - | $401.88M(+2.3%) |
| Jun 2022 | - | $393.03M(+8.6%) |
| Mar 2022 | - | $361.94M(+4.9%) |
| Dec 2021 | $344.93M(-13.4%) | $344.93M(-42.2%) |
| Sep 2021 | - | $596.56M(+5.8%) |
| Jun 2021 | - | $563.89M(+15.5%) |
| Mar 2021 | - | $488.16M(+22.6%) |
| Dec 2020 | $398.30M(+32.4%) | $398.30M(-30.4%) |
| Sep 2020 | - | $572.25M(+48.5%) |
| Jun 2020 | - | $385.24M(+9.7%) |
| Mar 2020 | - | $351.28M(+16.7%) |
| Dec 2019 | $300.88M(-27.9%) | $300.88M(+6.3%) |
| Sep 2019 | - | $283.01M(-9.2%) |
| Jun 2019 | - | $311.61M(-30.7%) |
| Mar 2019 | - | $449.68M(+7.8%) |
| Dec 2018 | $417.31M(+24.6%) | $417.31M(-0.1%) |
| Sep 2018 | - | $417.53M(+3.9%) |
| Jun 2018 | - | $402.03M(+8.5%) |
| Mar 2018 | - | $370.37M(+10.6%) |
| Dec 2017 | $334.89M | $334.89M(+6.8%) |
| Sep 2017 | - | $313.50M(-20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $393.48M(-2.2%) |
| Mar 2017 | - | $402.32M(+102.9%) |
| Dec 2016 | $198.25M(+92.9%) | $198.25M(+123.7%) |
| Sep 2016 | - | $88.61M(-17.6%) |
| Jun 2016 | - | $107.55M(+4.9%) |
| Mar 2016 | - | $102.49M(-0.3%) |
| Dec 2015 | $102.79M(+38.4%) | $102.79M(+17.2%) |
| Sep 2015 | - | $87.69M(+4.2%) |
| Jun 2015 | - | $84.15M(+1.0%) |
| Mar 2015 | - | $83.30M(+12.2%) |
| Dec 2014 | $74.25M(-588.7%) | $74.25M(+16.0%) |
| Sep 2014 | - | $64.02M(-19.4%) |
| Jun 2014 | - | $79.40M(-443.6%) |
| Mar 2014 | - | -$23.11M(+52.1%) |
| Dec 2013 | -$15.19M(-132.5%) | -$15.19M(+187.3%) |
| Sep 2013 | - | -$5.29M(-105.0%) |
| Jun 2013 | - | $105.66M(-9.1%) |
| Mar 2013 | - | $116.29M(+148.7%) |
| Dec 2012 | $46.77M(-7.8%) | $46.77M(-28.4%) |
| Sep 2012 | - | $65.30M(-23.0%) |
| Jun 2012 | - | $84.84M(+96.8%) |
| Mar 2012 | - | $43.11M(-15.0%) |
| Dec 2011 | $50.74M(+244.4%) | $50.74M(+98.4%) |
| Sep 2011 | - | $25.57M(-29.2%) |
| Jun 2011 | - | $36.13M(-18.6%) |
| Mar 2011 | - | $44.36M(+201.1%) |
| Dec 2010 | $14.73M(-888.7%) | $14.73M(+123.7%) |
| Sep 2010 | - | $6.58M(+37.5%) |
| Jun 2010 | - | $4.79M(-356.4%) |
| Dec 2009 | -$1.87M(-179.8%) | -$1.87M |
| Dec 2008 | $2.34M | - |
FAQ
- What is Pacira BioSciences annual working capital?
- What is the all time high annual working capital for Pacira BioSciences?
- What is Pacira BioSciences annual working capital year-on-year change?
- What is Pacira BioSciences quarterly working capital?
- What is the all time high quarterly working capital for Pacira BioSciences?
- What is Pacira BioSciences quarterly working capital year-on-year change?
What is Pacira BioSciences annual working capital?
The current annual working capital of PCRX is $435.21M
What is the all time high annual working capital for Pacira BioSciences?
Pacira BioSciences all-time high annual working capital is $435.21M
What is Pacira BioSciences annual working capital year-on-year change?
Over the past year, PCRX annual working capital has changed by +$22.60M (+5.48%)
What is Pacira BioSciences quarterly working capital?
The current quarterly working capital of PCRX is $445.23M
What is the all time high quarterly working capital for Pacira BioSciences?
Pacira BioSciences all-time high quarterly working capital is $596.56M
What is Pacira BioSciences quarterly working capital year-on-year change?
Over the past year, PCRX quarterly working capital has changed by -$4.44M (-0.99%)